Yiyun Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yiyun Cao has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Anjelica L. Martin
Department of Immunobiology, Yale School of Medicine, New Haven, USA
1 shared publication Deguang Song
Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06519, USA
1 shared publicationJaime A. Gonzalez-Hernandez
Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06519, USA
1 shared publication- Jason M. Crawford
Department of Chemistry, Yale University, New Haven, USA
1 shared publication - Jiawei Wang
Department of Psychiatry, Yale University School of Medicine, New Haven, USA
1 shared publication Joonseok Oh
Department of Chemistry, Yale University, New Haven, CT 06520, USA
1 shared publication
Latest Publications
- Top Cited Papers
- 28 October 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6618) , 369-+
Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
Microbiota-derived metabolites that elicit DNA damage can contribute to colorectal cancer (CRC). However, the full spectrum of genotoxic chemicals produced by indigenous gut microbes remains to be defined. We established a pipeline to systematically evaluate the genotoxicity of an extensive collection of gut commensals from inflammatory bowel disease patients. We identified isolates from divergent phylogenies whose metabolites caused DNA damage and discovered a distinctive family of genotoxins—termed the indolimines—produced by the CRC-associated species Morganella morganii. A non–indolimine-producing M. morganii mutant lacked genotoxicity and failed to exacerbate colon tumorigenesis in mice. These studies reveal the existence of a previously unexplored universe of genotoxic small molecules from the microbiome that may affect host biology in homeostasis and disease.
- 28 October 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6618) , 369-+
Top Cited PapersCommensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
Microbiota-derived metabolites that elicit DNA damage can contribute to colorectal cancer (CRC). However, the full spectrum of genotoxic chemicals produced by indigenous gut microbes remains to be defined. We established a pipeline to systematically evaluate the genotoxicity of an extensive collection of gut commensals from inflammatory bowel disease patients. We identified isolates from divergent phylogenies whose metabolites caused DNA damage and discovered a distinctive family of genotoxins—termed the indolimines—produced by the CRC-associated species Morganella morganii. A non–indolimine-producing M. morganii mutant lacked genotoxicity and failed to exacerbate colon tumorigenesis in mice. These studies reveal the existence of a previously unexplored universe of genotoxic small molecules from the microbiome that may affect host biology in homeostasis and disease.